MANE
Veradermics, Incorporated
NYSE: MANE · HEALTHCARE · BIOTECHNOLOGY
$99.00
-7.09% today
Updated 2026-04-30
Market cap
$3.74B
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-2.37
Dividend yield
—
52W range
$32 – $110
Volume
0.5M
Veradermics, Incorporated (MANE) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-72.10%
ROA
-43.40%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2023 | $0.00 | $-16.49M | — | — | — |
| 2024 | $0.00 | $-26.49M | — | — | — |
| 2025 | $0.00 | $-70.00M | — | — | — |